Compare AMST & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMST | IMCC |
|---|---|---|
| Founded | 2017 | 1980 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.8M | 10.4M |
| IPO Year | 2020 | N/A |
| Metric | AMST | IMCC |
|---|---|---|
| Price | $2.32 | $1.55 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 16.0K | ★ 124.9K |
| Earning Date | 10-24-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $193,505.00 | ★ $37,606,703.00 |
| Revenue This Year | N/A | $47.12 |
| Revenue Next Year | N/A | $12.83 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 68.56 | 1.92 |
| 52 Week Low | $2.00 | $0.93 |
| 52 Week High | $6.27 | $7.12 |
| Indicator | AMST | IMCC |
|---|---|---|
| Relative Strength Index (RSI) | 41.60 | 52.05 |
| Support Level | $2.25 | $1.54 |
| Resistance Level | $2.48 | $1.84 |
| Average True Range (ATR) | 0.16 | 0.17 |
| MACD | 0.04 | 0.03 |
| Stochastic Oscillator | 81.40 | 64.58 |
Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.